Clinico-pathological profile of female breast cancer in Kashmir: an institutional experience


  • Irfan Rasool Gadda Department of Radiation Oncology, Government Medical College, Srinagar, Jammu and Kashmir, India
  • Shiekh Owais Ahmad Department of Radiation Oncology, Government Medical College, Srinagar, Jammu and Kashmir, India
  • Sadaf Shafi Gadoo Department of Radiation Oncology, Government Medical College, Srinagar, Jammu and Kashmir, India



Breast carcinoma, Clinico-pathological profile, TNM


Background: Breast cancer is the most common cancer among women and one of the most important causes of death among them. The present study tries to evaluate the demographic, clinical, and pathological profile of female breast cancer patients in Kashmir

Methods: This study was done in government medical college Srinagar, department of radiation oncology. A retrospective review of 84 patients of breast cancer treated between January 2021 and March 2023 was done.

Results: A total of 84 patients were taken for this study. Most patients presented in the 4th and 5th decade of life with a mean age of 45.5± 8.58. 50% of the patients were having T2 followed by 19.04% having T4 and 16.66% having T1 while 14.28 % had T3 stage. 32.1% of patients were having N0 nodal status, 25.0% were having N3 followed by 23.80% had N1 and 19.04% had N2 nodal disease.52.38% were having stage II and 36.90% were having stage III and 4.76% were having stage IV. 85.71% were having invasive ductal carcinoma, 9.52% were having invasive lobular carcinoma and 4.76% were having medullary carcinoma. 23.80% of patients were Triple +, 27.38 % of patients were Triple Negative, 25.0% were ER+/ PR+.

Conclusions: The incidence of female breast cancer was more in the age group of 41–50 years. Stage II was more followed by Stage III. The most common histopathology type was invasive ductal carcinoma. Triple negativity was seen more in our patients.



Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. Cancer J Clin. 2021;71:209-49.

Cancer, International Agency for Research on Cancer. Available at: populations/356-india-fact-sheets.pdf. Accessed on 20 February 2023.

Wani MA, Jan FA, Khan NA, Pandita KK, Khurshid R, Khan SH. Cancer trends in Kashmir; common types, site incidence and demographic profiles: National Cancer Registry 2000-2012. Indian J Cancer. 2014;51(2):133-7.

Momenimovahed Z, Salehiniya H. Epidemiological characteristics of and risk factors for breast cancer in the world. Breast Cancer. 2019;11:151-164.

Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, et al. Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136:359 86.

Murthy NS, Agarwal UK, Chaudhry K, Saxena S. A study on time trends in incidence of breast cancer Indian scenario. Eur J Cancer Care. 2007;16:185 6.

Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A. AJCC cancer staging manual. 7th ed. New York: Springer; 2010:10.

Malvia S, Bagadi SA, Dubey US, Saxena S. Epidemiology of breast cancer in Indian women. Asia Pacific J Clin Oncol. 2017;13:289 95.

Das DS, Yengkhom IS, Sekar V, Akoijam S, A Adhikarimayum AD, Chongthu JL. Study of evolving trends in the clinicopathological profile of breast cancer patients attending a tertiary cancer centre. J Med Soc. 2019;33(2):71-5.

Wani SQ, Khan T, Wani SY, Koka AH, Arshad S, Rafiq L, et al. Clinicoepidemiological analysis of female breast cancer patients in Kashmir. J Cancer Res Therap. 2012;8:389-93.

Kumar N, Mukherjee S. Correlation of various prognostic factors in breast cancer. Int J Sci Engineer Res. 2013;3:1-4. .

Bera A, Banerjee C, Biswas L, Manna D. Epidemiology and prevalence of breast cancer: A retrospective study in a tertiary health care centre in Kolkata over one decade. Int J Med Sci Public Health. 2019;8:986-90.

Mistry S, Gandhi M, Patel P, Shah CK, Shah NR. A study of histopathological assessment of mastectomy specimens at the tertiary care centre in Western India. Int J Med Sci Public Health. 2013;3:2-12

Gogia A, Deo SV, Shukla NK, Mathur S, Sharma DN, Tiwari A. Clinicopathological profile of breast cancer: an institutional experience. Indian J Cancer. 2018; 55(3):210-3.

Nair N, Shet T, Parmar V, Havaldar R, Gupta S, Budrukkar A, et al. Breast cancer in a tertiary cancer centre in India - an audit, with outcome analysis. Indian J Cancer. 2018;55(1):16-22.

Camacho LH, Kurzrock R, Cheung A, Barber DF, Gupta S, Madoff DC, et al. Pilot study of regional, hepatic intra-arterial paclitaxel in patients with breast carcinoma metastatic to the liver. Cancer. 2007; 109(11):2190-6.

Abitra D, Das S, Jan A, Tapas K, Das R. Demographic, clinicopathological profile, and immunohistochemistry study in female breast cancer in Eastern India: A hospital-based retrospective Study. Asian J Pharmacol Clin Res. 2022;15(12):122-5.

Singh R, Kumar A, Tudu R, Munda PK. Clinical and estrogen receptor, progesterone receptor, and human epidermal growth factor receptor-2 status correlation study in breast cancer patients: An experience from a tertiary care centre. J Rad Cancer Res. 2020;11:157-60.

Kakarala M, Rozek L, Cote M, Liyanage S, Brenner DE. Breast cancer histology and receptor status characterization in Asian Indian and Pakistani women in the U.S.-a SEER analysis. Biomed Central Cancer. 2010;10:191.




How to Cite

Gadda, I. R., Ahmad, S. O., & Gadoo , S. S. (2023). Clinico-pathological profile of female breast cancer in Kashmir: an institutional experience. International Journal of Research in Medical Sciences, 11(8), 2991–2994.



Original Research Articles